Skip to main content
. 2023 Apr 3;12(4):870. doi: 10.3390/antiox12040870

Figure 3.

Figure 3

Sal A ameliorates inflammation in vivo and in vitro. (A–C) Sal A pretreatment for 3 days followed by APAP stimulation in mice. (A,B) Serum TNF-α and IL-1β levels were determined by ELISA, n = 8. (C) The protein level of NF-κB in mice, n = 3. (D–F) AML12 cells were incubated with Sal A before exposure to APAP. (D,E) TNF-α and IL-1β levels were determined by ELISA, n = 8. (F) The protein levels of NF-κB in AML12 cells, n = 3. * p < 0.05, ** p < 0.01 vs. control. # p < 0.05, ## p < 0.01 vs. APAP.